Fotios Barkas/ LinkedIn
Sep 1, 2025, 07:37
Fotios Barkas Highlights Key Updates in ESC2025 Dyslipidemia Guidelines
Fotios Barkas, Assistant Professor of Internal Medicine University of Ioannina, shared a noteworthy post on LinkedIn:
“Just released in ESC2025: Updated Dyslipidemia Guidelines
Key highlights:
- CAC Score for risk
- LDL-C cutoffs for LLL initiation
- Bempedoic acid and Evinacumab
- Lp(a) ≥50 mg/dL as a cutoff
- Intensification of LLM post-ACS
- EPA only
- Volanesorsen in FCS, statins in HIV, and anthracyclin-induced cardiotoxicity
- Dietary supplements”
Stay updated with Hemostasis Today.
Bempedoic Acid
CAC Score
Cardiotoxicity
cardiovascular risk
Dietary Supplements
Dyslipidemia Guidelines
EPA
ESC 2025
European Atherosclerosis Society
Evinacumab
Familial Chylomicronemia Syndrome
Health
Hematology
Hemostasis Today
HIV
LDL Cholesterol
Lipid Lowering Therapy
Lipoprotein a
Medicine
Post ACS Management
statins
Volanesorsen
-
Mar 10, 2026, 13:17Jeannie Devereaux: A Novel Technique for Precise High-Dose PRP Injection in Hip Labral Tear
-
Mar 10, 2026, 13:13Wolfgang Miesbach: Highlighting a Critical and Overlooked Dimension of Rare Bleeding Disorders in Women at EAHAD 2026
-
Mar 10, 2026, 13:08Michael Ertl: Honoured To Be Elected Fellow of the European Stroke Organisation
-
Mar 10, 2026, 13:00Nita Radhakrishnan: Benchmarking Hemophilia Care Across Global Income Settings Using Data from India
-
Mar 10, 2026, 12:59Hisam Siddiqi: Night Sweats Are Not Always a Hematological Plot Twist
-
Mar 10, 2026, 12:54Tzu-Fei Wang: Reassuring Real-World Data for Clinicians to Guide Anticoagulation in Prostate Cancer
-
Mar 10, 2026, 12:54RishiRaj Sinha: Connecting Researchers Driving the Future of Stem Cell Science at ISSCR 2026
-
Mar 10, 2026, 12:48Kayley Pappas: Stroke Care is Evolving and Mayo Clinic Is Helping Lead The Way
-
Mar 10, 2026, 12:47Jimmy Lowery: The Clinical and Financial Responsibilities of Blood Bank Inventory